Abstract:Ewelina Waglewska, 1 Julita Kulbacka, 2, 3 Urszula Bazylinska 1 1 Department of Physical and Quantum Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland; 2 Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland; 3 State Research Institute Centre for Innovative Medicine, Department of Immunology and Bioelectrochemistry, Vilnius, Lithuania Correspondence: Urszula Bazylinska, Department of Physical and Quantum Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, Wroclaw, 50-370, Poland, Tel +48 713202183, Email Purpose: Numerous failures in melanoma treatment as a highly aggressive form of skin cancer with an unfavorable prognosis and excessive resistance to conventional therapies are prompting an urgent search for more effective therapeutic tools. Consequently, to increase the treatment efficiency and to reduce the side effects of traditional administration ways, herein, it has become crucial to combine photodynamic therapy as a promising therapeutic approach with the selectivity and biocompatibility of a novel colloidal transdermal nanoplatform for effective delivery of hybrid cargo with synergistic effects on melanoma cells. Methods: The self-assembled bilosomes, co-stabilized with L-α-phosphatidylcholine, sodium cholate, Pluronic ® P123, and cholesterol, were designated, and the stability of colloidal vesicles was studied using dynamic and electrophoretic light scattering, also provided in cell culture medium (Dulbecco's Modified Eagle's Medium). The hybrid compounds – a classical photosensitizer (Methylene Blue) along with a complementary natural polyphenolic agent (curcumin), were successfully co-loaded, as confirmed by UV-Vis, ATR-FTIR, and fluorescent spectroscopies. The biocompatibility and usefulness of the polymer functionalized bilosome with loaded double cargo were demonstrated in vitro cyto- and phototoxicity experiments using normal keratinocytes and melanoma cancer cells. Results: The in vitro bioimaging and immunofluorescence study upon human skin epithelial (A375) and malignant (Me45) melanoma cell lines established the protective effect of the PEGylated bilosome surface. This effect was confirmed in cytotoxicity experiments, also determined on human cutaneous (HaCaT) keratinocytes. The flow cytometry experiments indicated the enhanced uptake of the encapsulated hybrid cargo compared to the non-loaded MB and CUR molecules, as well as a selectivity of the obtained nanocarriers upon tumor cell lines. The phyto-photodynamic action provided 24h-post irradiation revealed a more significant influence of the nanoplatform on Me45 cells in contrast to the A375 cell line, causing the cell viability rate below 20% of the control. Conclusion: As a result, we established an innovative and effective strategy for potential metastatic melanoma treatment through the synergism of phyto-photodynamic therapy and novel bilosomal-origin nanophotosensitizers. Keywords: nanovesicular carriers, human melanoma, A375 cells, Me45 cells, antitumor activity, phyto-photodynamic therapy Graphical The level of cancer incidence has dramatically increased over recent years. Prominent among them is malignant melanoma, diagnosed each year in about 1.7% of primary malignancies and contributing to 0.7% of cancer-related deaths. 1 Melanocyte-derived melanoma, usually found in the innermost part of the epidermis (basal layer), is the most malignant type of skin cancer due to its rapid growth rate and numerous metastases. It can spread to various body parts, from draining lymph nodes to distant visceral organs, especially the brain, lungs, bones, and liver. In addition to surgical resection, standard clinical treatments include chemotherapy, radiation therapy, and immunotherapy. Targeted therapy based on gene editing tools, among other approaches, has also received tremendous attention in the field of melanoma treatment. 2,3 However, the inherent resistance of melanoma to traditional methods (especially for metastatic forms) is a severe concern for modern oncology, which motivates scientists to develop emerging strategies to fight melanoma. 4–6 Due to its high degree of efficacy, safety of use, and non-invasiveness, photodynamic therapy (PDT) is a therapeutic approach that has attracted considerable interest among researchers for many cancer treatments. PDT is now FDA-approved as one of the methods officially used to treat basal cell and squamous cell carcinoma (a group of cancers developing in the upper layers of the skin), as well as certain types of esophageal and lung -Abstract Truncated-

A Yeast Cell Wall Derived Hybrid Hydrogel with Photothermal and Immune Combined Modality Therapy for Enhanced Anti-Melanoma Efficacy

Gold Nanocage-Based Photothermal Ablation Facilitates in Situ Vaccination for Melanoma Therapy.

Tumor Immunotherapy Boosted by R837 Nanocrystals Through Combining Chemotherapy and Mild Hyperthermia.

Combining Photothermal Therapy and Immunotherapy Against Melanoma by Polydopamine-Coated Al2O3 Nanoparticles

Enhancing melanoma therapy by modulating the immunosuppressive microenvironment with an MMP-2 sensitive and nHA/GNE co-encapsulated hydrogel

Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application

Enhanced anti-tumor efficacy of temozolomide-loaded carboxylated poly(amido-amine) combined with photothermal/photodynamic therapy for melanoma treatment

B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma

Chemocentric Chemoimmunotherapy: A New Concept in Melanoma Immunotherapy

Photothermal Therapy Mediated by Phase-Transformation Nanoparticles Facilitates Delivery of Anti-Pd1 Antibody and Synergizes with Antitumor Immunotherapy for Melanoma

Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy

Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment

Peptide-IR820 Conjugate: A Promising Strategy for Efficient Vascular Disruption and Hypoxia Induction in Melanoma

Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy.

Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer

NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma

In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy

A Multifunctional Low-Temperature Photothermal Nanomedicine for Melanoma Treatment via the Oxidative Stress Pathway Therapy

Pioneering Astaxanthin-Tumor Cell Membrane Nanoparticles for Innovative Targeted Drug Delivery on Melanoma

Cell Membrane Camouflaged Biomimetic Nanocomplex Based on Black Phosphorus Nanosheets to Modulate T Cells for Melanoma Immunotherapy

Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel